The K-factor in chronic kidney disease: Biomarkers of calcification inhibition and beyond

Nephrology Dialysis Transplantation

Volumn 29, Issue 7, 2014, Pages 1267-1270

  Ketteler, Markus ^a   Rothe, Hansjörg ^a   Brandenburg, Vincent M ^b   Westenfeld, Ralf ^c  

^a KLINIKUM COBURG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FARNOQUINONE; PHYTOMENADIONE; PROTEIN; UNCLASSIFIED DRUG; VITAMIN K DEPENDENT MATRIX GLA PROTEIN; VITAMIN K GROUP;

ARTERY DISEASE; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIFIC UREMIC ARTERIOLOPATHY; CARBOXYLATION; CARBOXYLATION AND DECARBOXYLATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RISK FACTOR; VITAMIN SUPPLEMENTATION;

CALCIUM-BINDING PROTEINS; DIETARY SUPPLEMENTS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HEMOSTATICS; HUMANS; MALE; RENAL DIALYSIS; VITAMIN K 2;

EID: 84903833958     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu053     Document Type: Article

References (19)

1. Ketteler M, Rothe H, Krüger T et al. Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nat Rev Nephrol 2011.; 7: 509-516
2. Jahnen-Dechent W, Heiss A, Schäfer C et al. Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011.; 108: 1494-1509
3. Krueger t, westenfeld r, ketteler m et al
4. Cranenburg EC, Schurgers LJ, Uiterwijk HH et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012.; 82: 605-610
5. Caluwé R, van Vlem B, Vermeer C et al. Vitamin K2 supplementation in hemodialysis patients: A randomized dosefinding study. Nephrol Dial Transplant 2014.; 29: 1385-1390
6. Block GA, Wheeler DC, Persky MS et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012.; 23: 1407-1415
7. Hill KM, Martin BR, Wastney ME et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 2013.; 83: 959-966
8. Jamal SA, Vandermeer B, Raggi P et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-Analysis. Lancet 2013.; 382: 1268-1277
9. Raggi P, Chertow GM, Torres PU et al. The ADVANCE study: A randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011.; 26: 1327-1339
10. Moe SM, O'Neill KD, Reslerova M et al. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 2004.; 19: 2387-2393
11. Cranenburg EC, Koos R, Schurgers LJ et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010.; 104: 811-822
12. Westenfeld R, Krueger T, Schlieper G et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 2012.; 59: 186-195
13. Geleijnse JM, Vermeer C, Grobbee DE et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J Nutr 2004.; 134: 3100-3105
14. Fusaro M, Noale M, Viola V et al. Vitamin K Italian (VIKI) Dialysis Study Investigators. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012.; 27: 2271-2278
15. Hayashi M, Takamatsu I, Kanno Y et al. Japanese Calciphylaxis Study Group. A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 2012.; 27: 1580-1584
16. Nigwekar SU, Bhan I, Turchin A et al. Statin use and calcific uremic arteriolopathy: A matched case-control study. Am J Nephrol 2013.; 37: 325-332
17. Vissers LE, Dalmeijer GW, Boer JM et al. Intake of dietary phylloquinone and menaquinones and risk of stroke. J Am Heart Assoc 2013.; 2: E000455
18. Lonn E, Yusuf S, Arnold MJ et al. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006.; 354: 1567-1577
19. Krueger T, Schlieper G, Schurgers L et al. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): A rationale and study protocol. Nephrol Dial Transplant 2013.; doi: 10.1093/ndt/gft459